All Companies
Ticker BIAF
We can't analyze this yet — its market data looks wrong
You reached the page — here's exactly what BIAF is, and why it's out of scope for now.
What this ticker is
BIAF
BioAffinity Technologies Inc.
NASDAQ
Healthcare
Diagnostics & Research
Why we can't analyze it yet
Data provider – reported cap ($3,313,605) is 20.9× off vs SEC filings (8,101,725 shares × $8.56 ≈ $69,310,257); source data unreliable
Delvantic analyzes regular securities of single operating companies — one business with revenue, earnings and cash flows our valuation methods can assess bottom-up.
Reason code:
data_corrupt